cagrilintide prescription Cagrilintide is a long-acting amylin

Gopal Grandhige, MD, FACS, Board-Certified Surgeon Last Reviewed: May 12, 2026 Cagrilintide is a long-acting amylin receptor agonist used in peptide-based weight management, and like any medication, it carries potential side effects that patients should understand before starting treatment

Lyophilized Storage Store below -18C, stable up to 24 months

GLOW Peptide Therapy The GLOW peptide is a specialty peptide blend designed to enhance skin health, collagen production, and overall rejuvenation from within

Unlike Ozempic, these compounds are not FDA-approved medications

That combination, known as CagriSema, became one of the most closely watched developments in obesity pharmacology